fda compounding semaglutide enforcement october 2025 news September 2, 2025: U.S. restrictions have stemmed a flood of compounded and tirzepatide – Partnership for Safe Medicines Maybe i’m not against compounding
Description
What Are the Cardiovascular Outcomes of Semaglutide in Patients With Type 2 Diabetes and Cardiovascular Disease
2021;131(2):e142243
Prescribing should follow current NICE guidance and licensing indications
After MBS, especially after SG and RYGB, GLP-1 and peptide YY (PYY) levels increase, ghrelin levels decrease, and the peak rise (at 1530 min) in GLP-1 levels after mixed meal test or oral glucose tolerance test (OGTT) is higher than before BMS [12, 13]
the MHRA has issued advice on the dangers of purchasing medicines from unregulated sources
